203 reports of this reaction
1.1% of all FORMOTEROL FUMARATE reports
#19 most reported adverse reaction
HYPOTHYROIDISM is the #19 most commonly reported adverse reaction for FORMOTEROL FUMARATE, manufactured by Alembic Pharmaceuticals Inc.. There are 203 FDA adverse event reports linking FORMOTEROL FUMARATE to HYPOTHYROIDISM. This represents approximately 1.1% of all 18,067 adverse event reports for this drug.
Patients taking FORMOTEROL FUMARATE who experience hypothyroidism should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOTHYROIDISM is a less commonly reported adverse event for FORMOTEROL FUMARATE, but still significant enough to appear in the safety profile.
In addition to hypothyroidism, the following adverse reactions have been reported for FORMOTEROL FUMARATE:
The following drugs have also been linked to hypothyroidism in FDA adverse event reports:
HYPOTHYROIDISM has been reported as an adverse event in 203 FDA reports for FORMOTEROL FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOTHYROIDISM accounts for approximately 1.1% of all adverse event reports for FORMOTEROL FUMARATE, making it a notable side effect.
If you experience hypothyroidism while taking FORMOTEROL FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.